ISRG
Price
$443.85
Change
+$15.73 (+3.67%)
Updated
Oct 22 closing price
Capitalization
156.8B
96 days until earnings call
Intraday BUY SELL Signals
VREX
Price
$18.41
Change
-$0.01 (-0.05%)
Updated
Oct 22 closing price
Capitalization
781.75M
26 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ISRG vs VREX

ISRG vs VREX Comparison Chart in %
View a ticker or compare two or three
VS
ISRG vs. VREX commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISRG is a Hold and VREX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ISRG with price predictions
Oct 22, 2026

ISRG in -1.73% downward trend, sliding for three consecutive days on October 14, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ISRG declined for three days, in 162 of 264 cases, the price declined further within the following month. The odds of a continued downward trend are 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ISRG moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 10 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 27%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

ISRG broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on ISRG as a result. In 56 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

The 10-day moving average for ISRG crossed bullishly above the 50-day moving average on September 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 45%.

Following a +2.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where ISRG advanced for three days, in 210 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

The Aroon Indicator entered an Uptrend today. In 183 of 264 cases where ISRG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. ISRG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 51 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ISRG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.631) is normal, around the industry mean (4.961). P/E Ratio (50.209) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (1.931) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (12.469) is also within normal values, averaging (56.876).

A.I.Advisor
a Summary for VREX with price predictions
Oct 22, 2026

VREX's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for VREX moved out of overbought territory on October 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In 20 of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VREX as a result. In 62 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.

VREX moved below its 50-day moving average on October 19, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VREX crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VREX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for VREX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 61 cases where VREX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

Following a +0.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where VREX advanced for three days, in 200 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

VREX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. VREX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.574) is normal, around the industry mean (2.874). P/E Ratio (34.093) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (4.979) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.903) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VREX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
ISRG vs VREX: Fundamental Ratings
ISRG
VREX
OUTLOOK RATING
1..100
2768
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
5184
PRICE GROWTH RATING
1..100
4436
P/E GROWTH RATING
1..100
756
SEASONALITY SCORE
1..100
4719

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ISRG's Valuation (81) in the Medical Specialties industry is in the same range as VREX (93). This means that ISRG’s stock grew similarly to VREX’s over the last 12 months.

ISRG's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as VREX (100). This means that ISRG’s stock grew similarly to VREX’s over the last 12 months.

ISRG's SMR Rating (51) in the Medical Specialties industry is somewhat better than the same rating for VREX (84). This means that ISRG’s stock grew somewhat faster than VREX’s over the last 12 months.

VREX's Price Growth Rating (36) in the Medical Specialties industry is in the same range as ISRG (44). This means that VREX’s stock grew similarly to ISRG’s over the last 12 months.

VREX's P/E Growth Rating (6) in the Medical Specialties industry is significantly better than the same rating for ISRG (75). This means that VREX’s stock grew significantly faster than ISRG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ISRGVREX
RSI
ODDS (%)
Bearish Trend 1 day ago
27%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
70%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 24 days ago
64%
Declines
ODDS (%)
Bearish Trend 9 days ago
61%
Bearish Trend 4 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
60%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
66%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ISRG: $443.85 vs. VREX: $18.42)
Brand notoriety: ISRG: Notable vs. VREX: Not notable
ISRG represents the Pharmaceuticals: Other, while VREX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ISRG: 119% vs. VREX: 61%
Market capitalization -- ISRG: $156.8B vs. VREX: $781.75M
ISRG [@Pharmaceuticals: Other] is valued at $156.8B. VREX’s [@Medical/Nursing Services] market capitalization is $781.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.45B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ISRG’s FA Score shows that 0 FA rating(s) are green while VREX’s FA Score has 1 green FA rating(s).

  • ISRG’s FA Score: 0 green, 5 red.
  • VREX’s FA Score: 1 green, 4 red.
According to our system of comparison, VREX is a better buy in the long-term than ISRG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ISRG’s TA Score shows that 4 TA indicator(s) are bullish while VREX’s TA Score has 3 bullish TA indicator(s).

  • ISRG’s TA Score: 4 bullish, 4 bearish.
  • VREX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ISRG is a better buy in the short-term than VREX.

Price Growth

ISRG (@Pharmaceuticals: Other) experienced а +3.74% price change this week, while VREX (@Medical/Nursing Services) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

ISRG is expected to report earnings on Jan 26, 2027.

VREX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
ISRG
Daily Signal:
Gain/Loss:
VREX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

VREX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VREX has been loosely correlated with NVST. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
-0.05%
NVST - VREX
51%
Loosely correlated
+3.36%
ATR - VREX
47%
Loosely correlated
+1.97%
A - VREX
47%
Loosely correlated
-2.17%
ISRG - VREX
43%
Loosely correlated
+3.67%
DHR - VREX
43%
Loosely correlated
-1.76%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HURN193.3510.03
+5.47%
Huron Consulting Group
LEXX2.950.13
+4.61%
Lexaria Bioscience Corp
OIO1.880.03
+1.62%
OIO Group
UP3.21-0.06
-1.83%
Wheels Up Experience
FSLR171.25-3.57
-2.04%
First Solar